Back

Stratification of cancer-therapy related cardiac dysfunction: a validated prediction tool to identify low risk patients.

30 August 2026 (15:18 - 15:30)
Organised by: Logo
Congress Presentation Part of: Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Jose Ramon Gonzalez Juanatey

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

4 More presentations in this session

Presentation thumbnail
Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort
Mr J. Singh (US)
Abstract
Presentation thumbnail
Artificial intelligence–enabled electrocardiography as a pre-treatment predictor of chemotherapy-related cardiac dysfunction
Doctor M. Lee (Bucheon, KR)
Abstract
Presentation thumbnail
GLP-1 receptor agonists for anthracycline-associated cardiac outcomes: first meta-analytic evaluation in propensity-matched cohorts
Mr A. Chauhan (IN)
Abstract
Presentation thumbnail
Healthcare utilization and costs in cancer therapy-related heart failure: a national inpatient sample analysis
Doctor L. Cruz (Santiago de los Caballeros, DO)
Abstract

Access the full session

Session thumbnail
Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection

The Event

Event poster

ESC Congress 2026

30 August 2026 15:18 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of ESC risk stratification for cancer therapy-related cardiovascular toxicity in a real-world urban population
1 September 2025
thumbnail
Congress Presentation
Biomarkers' ability to predict cardiac toxicity in oncological patients undergoing to antineoplastic treatment: 5-year follow-up
28 August 2020
thumbnail
Congress Presentation
The delicate balance of permissive cardiotoxicity strategy in cancer-related cardiac dysfunction at a tertiary Centre: a comparative analysis
20 June 2025
thumbnail
Congress Presentation
Study of variables in the stratification of risk in acute myocarditis: results from a tertiary hospital cohort
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources